Many CMC Deficiencies Can Be Easily Corrected, FDA Finds
This article was originally published in The Gold Sheet
Executive Summary
When FDA looked back at 291 complete response letters the agency recently issued after first-cycle generic drug reviews, the results were surprisingly encouraging.